% | $
Quotes you view appear here for quick access.

Xenoport, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eastcoast770 eastcoast770 Apr 4, 2011 3:14 PM Flag

    No strong arguments about approval or denial, WHY???

    In the case of Arena's rat cancer issues with the FDA, must be addressed as required in their CRL request back in December 2010. The company has yet to submit their studies data, therefore no 2nd CRL.

3.93-0.16(-3.91%)Oct 8 4:00 PMEDT